Rekhtman et al. suggested that LCNEC can be divided into non-SCLC-type and SCLC-type based on the frequency of STK11, KEAP1, or NOTCH1-4 mutations [9]. This evidence concerns the gene KEAP1 and large cell neuroendocrine carcinoma.